Welcome to our dedicated page for Aptiv Plc SEC filings (Ticker: APTV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aptiv PLC (NYSE: APTV) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, including Form 8-K current reports and other key documents filed with the Securities and Exchange Commission. As a Jersey-organized issuer with ordinary shares and multiple series of notes listed on the New York Stock Exchange, Aptiv uses these filings to report material events, financial results, capital markets transactions and significant corporate actions.
Recent Form 8-K filings show how Aptiv communicates quarterly performance and outlook, with reports tied to its financial results for periods ended June 30 and September 30. These filings reference press releases that detail revenue, operating income, non-GAAP measures such as Adjusted EBITDA and Adjusted Net Income, and guidance ranges, along with explanations of how management uses non-GAAP metrics to assess ongoing performance.
Other 8-Ks document governance and strategic developments. For example, Aptiv reported the appointment of Håkan Agnevall to its Board of Directors and disclosed the filing of a preliminary Form 10 by Cyprium Holdings Limited in connection with the intended separation of Aptiv’s Electrical Distribution Systems business into a new, independent publicly traded company, planned to be completed by March 31, 2026, subject to customary closing conditions. Additional filings list Aptiv’s various senior notes and fixed-to-fixed reset rate junior subordinated notes that are registered under Section 12(b) of the Exchange Act.
On Stock Titan, these SEC filings are complemented by AI-powered tools that help explain the structure and implications of documents such as 8-Ks, 10-Ks, 10-Qs and Form 4 insider transaction reports. Real-time updates from EDGAR, combined with AI-generated summaries, can assist users in quickly understanding Aptiv’s reported results, capital structure, governance changes and planned corporate transactions without reading every line of each filing.
Aptiv PLC executive Katherine H. Ramundo, EVP, CLO, CCO & Secretary, reported equity compensation awards in the form of ordinary shares. She was granted 28,179 ordinary shares and a separate 18,786-share award, both recorded at zero purchase price as grants rather than open-market purchases.
Footnotes state one award will vest in three equal installments beginning on February 28, 2027, and that totals reflect adjustments to outstanding awards related to the spin-off of Versigent PLC. Another award consists of performance shares that may convert into ordinary shares based on specified performance criteria over a period from January 1, 2026 to December 31, 2028.
Massaro Joseph R reported acquisition or exercise transactions in this Form 4 filing.
Aptiv PLC reported that Vice Chair & President, EC Joseph R. Massaro received two equity awards of ordinary shares as compensation. On April 22, 2026, he was granted 62,898 ordinary shares at no cost and a separate award of 41,933 ordinary shares, also at no cost.
The filing notes that some of these shares will vest in three equal installments beginning on February 28, 2027, and that certain performance shares are contingent on achieving specified performance criteria over a period from January 1, 2026 to December 31, 2028.
Aptiv PLC reported that EVP & Chief People Officer Obed D. Louissaint acquired equity-based compensation in the form of ordinary shares. He received grants of 34,216 and 22,812 ordinary shares at a stated price of $0.00 per share, reflecting stock awards rather than open-market purchases.
According to the footnotes, one award will vest in three equal installments beginning on February 28, 2027. Another award is structured as performance shares, each representing a contingent right to receive one ordinary share, which will vest based on specified performance criteria over a performance period from January 1, 2026 to December 31, 2028. These transactions increase his direct holdings and represent routine executive compensation, not market trading activity.
Aptiv PLC EVP & Chief Financial Officer Varun Laroyia reported two share-based award grants. He acquired 42,771 ordinary shares as a grant that will vest in three equal installments beginning on February 28, 2027.
He also acquired 28,514 performance shares, each representing a contingent right to receive one ordinary share of Aptiv PLC. These performance shares will vest based on specified performance criteria measured over a performance period from January 1, 2026 to December 31, 2028. Following these awards, he holds 230,962 ordinary shares directly. Total reported awards also reflect adjustments related to the spin-off of Versigent PLC.
CLARK KEVIN P reported acquisition or exercise transactions in this Form 4 filing.
Aptiv PLC Chair and CEO Kevin P. Clark received new equity awards in the form of ordinary shares. He was granted 145,924 shares and an additional 97,283 shares at no cash cost, increasing his directly held stake to 599,826 shares.
Separately, 727,210 shares are held indirectly through the Kevin P. Clark Revocable Trust. According to the footnotes, some of these awards will vest in three equal installments beginning on February 28, 2027, and certain performance shares vest based on performance criteria over a period from January 1, 2026 to December 31, 2028.
Brazier Allan J reported acquisition or exercise transactions in this Form 4 filing.
Aptiv PLC disclosed that SVP & Chief Accounting Officer Allan J. Brazier received equity awards totaling 15,096 ordinary shares on April 22, 2026. These were granted as compensation at no cash cost to him. The awards include time-based shares that vest in three equal installments beginning on February 28, 2027, and performance shares that may vest based on specified performance criteria over a period from January 1, 2026 to December 31, 2028. The filing reflects routine equity compensation rather than open-market buying or selling.
The New York Stock Exchange LLC filed Form 25 to remove from listing and withdraw registration the 4.650% Senior Notes due 2029 issued by Aptiv PLC. The Form 25 cites compliance with 17 CFR 240.12d2-2 procedures; the exchange's market watch manager signed the notice.
Aptiv PLC filed an amended report to provide unaudited pro forma financial statements reflecting the spin-off of its Electrical Distribution Systems business into Versigent PLC. The spin-off distributed one Versigent share for every three Aptiv shares held on March 17, 2026, with cash paid for fractional shares.
Versigent now trades independently on the NYSE under “VGNT,” and Aptiv no longer owns Versigent or consolidates its results, which will be shown as discontinued operations from the second quarter of 2026. Pro forma 2025 figures show continuing operations net sales of $12.4 billion and a net loss attributable to Aptiv of $43 million, or $(0.20) per share.
In connection with the separation, Versigent incurred $2,100 million of new debt and made a $2,125 million cash distribution to Aptiv. Aptiv intends to use about $2,113 million to repay debt, including redemptions of certain 2029 notes and a tender offer for up to $1,371 million of other senior notes.
Aptiv PLC has completed a cash tender offer, through its subsidiary Aptiv Swiss Holdings Limited, to repurchase multiple series of outstanding senior notes for aggregate consideration of up to $1,371,000,000. The offer, which expired on April 3, 2026, was conditioned on completing the spin-off of its Electrical Distribution Systems business into Versigent and receiving a special dividend from Versigent of at least $1,700,000,000, and those conditions have been met.
Aptiv will purchase accepted notes across several maturities, including $456,533,000 of 3.250% Senior Notes due 2032, $370,519,000 of 5.150% Senior Notes due 2034 and $303,808,000 of 5.750% Senior Notes due 2054. Some longer-dated series were capped, such as the 4.150% Senior Notes due 2052, where a 19.2% proration factor limited purchases to $79,619,000. Settlement is expected on April 7, 2026.
Aptiv PLC has completed the previously announced spin-off of Versigent Limited, separating it into an independent company. The spin-off was executed through a pro rata distribution of all Versigent ordinary shares to Aptiv shareholders.
Each Aptiv shareholder of record on March 17, 2026 received one Versigent share for every three Aptiv ordinary shares held, with cash paid instead of fractional Versigent shares. The distribution occurred on April 1, 2026 at 12:01 a.m. Eastern time.
Versigent’s ordinary shares began trading on the New York Stock Exchange under the ticker symbol “VGNT” on April 1, 2026. A Separation and Distribution Agreement between Aptiv and Versigent governs the spin-off and ongoing relationships, and Aptiv plans to file required pro forma financial information by amendment.